Latest filing published 19 Dec 2025 for Cogent Biosciences, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Cole Pinnow in Cogent Biosciences, Inc. Over a trading history stretching from 14 January 2025 to 17 December 2025, the count stands at 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €324k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants.
The record was last updated on 19 December 2025 with a share grant in Cogent Biosciences, Inc. The last purchase on record was published on 15 January 2025, which is 647 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations